These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 25704190)
1. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients. Xing ZY; Sun LG; Guo WJ Clin Neurol Neurosurg; 2015 Apr; 131():54-8. PubMed ID: 25704190 [TBL] [Abstract][Full Text] [Related]
2. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment. Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967 [TBL] [Abstract][Full Text] [Related]
3. Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC Mol Med Rep; 2013 Jan; 7(1):139-43. PubMed ID: 23076250 [TBL] [Abstract][Full Text] [Related]
4. Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation. Di Bari M; Bevilacqua V; De Jaco A; Laneve P; Piovesana R; Trobiani L; Talora C; Caffarelli E; Tata AM Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857516 [TBL] [Abstract][Full Text] [Related]
5. Contribution of Notch signaling activation to human glioblastoma multiforme. Kanamori M; Kawaguchi T; Nigro JM; Feuerstein BG; Berger MS; Miele L; Pieper RO J Neurosurg; 2007 Mar; 106(3):417-27. PubMed ID: 17367064 [TBL] [Abstract][Full Text] [Related]
6. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
7. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status. Navarro L; Gil-Benso R; Megías J; Muñoz-Hidalgo L; San-Miguel T; Callaghan RC; González-Darder JM; López-Ginés C; Cerdá-Nicolás MJ Neuroscience; 2015 Jun; 297():243-51. PubMed ID: 25869624 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome. Bai Y; Zhang QG; Wang XH Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217 [TBL] [Abstract][Full Text] [Related]
9. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Chigurupati S; Venkataraman R; Barrera D; Naganathan A; Madan M; Paul L; Pattisapu JV; Kyriazis GA; Sugaya K; Bushnev S; Lathia JD; Rich JN; Chan SL Cancer Res; 2010 Jan; 70(1):418-27. PubMed ID: 20028870 [TBL] [Abstract][Full Text] [Related]
10. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047 [TBL] [Abstract][Full Text] [Related]
11. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme. Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543 [TBL] [Abstract][Full Text] [Related]
12. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression. Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients. Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948 [TBL] [Abstract][Full Text] [Related]
15. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma. Liu YS; Lin HY; Lai SW; Huang CY; Huang BR; Chen PY; Wei KC; Lu DY Oncogene; 2017 Aug; 36(35):5006-5022. PubMed ID: 28459461 [TBL] [Abstract][Full Text] [Related]
16. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386 [TBL] [Abstract][Full Text] [Related]
17. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294 [TBL] [Abstract][Full Text] [Related]
18. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969 [TBL] [Abstract][Full Text] [Related]
19. Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. Saikali S; Avril T; Collet B; Hamlat A; Bansard JY; Drenou B; Guegan Y; Quillien V J Neurooncol; 2007 Jan; 81(2):139-48. PubMed ID: 17004103 [TBL] [Abstract][Full Text] [Related]